A detailed history of Harbour Investments, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Harbour Investments, Inc. holds 7,494 shares of NVS stock, worth $772,556. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,494
Previous 7,499 0.07%
Holding current value
$772,556
Previous $798,000 7.89%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$106.13 - $120.89 $530 - $604
-5 Reduced 0.07%
7,494 $861,000
Q2 2024

Jul 26, 2024

BUY
$92.57 - $107.37 $25,271 - $29,312
273 Added 3.78%
7,499 $798,000
Q1 2024

Jul 22, 2024

BUY
$95.27 - $108.47 $4,858 - $5,531
51 Added 0.71%
7,226 $698,000
Q4 2023

Feb 16, 2024

BUY
$92.27 - $101.54 $15,132 - $16,652
164 Added 2.34%
7,175 $724,000
Q3 2023

Nov 15, 2023

SELL
$94.73 - $105.13 $17,619 - $19,554
-186 Reduced 2.58%
7,011 $714,000
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $26,275 - $29,794
-284 Reduced 3.8%
7,197 $726,000
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $33,532 - $38,887
419 Added 5.93%
7,481 $688,000
Q4 2022

Feb 15, 2023

BUY
$75.55 - $92.52 $318,518 - $390,064
4,216 Added 148.14%
7,062 $640,000
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $13,205 - $15,375
164 Added 6.11%
2,846 $241,000
Q4 2021

Feb 16, 2022

SELL
$79.7 - $88.13 $188,171 - $208,074
-2,361 Reduced 46.82%
2,682 $235,000
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $25,106 - $29,207
307 Added 6.48%
5,043 $412,000
Q2 2021

Aug 16, 2021

BUY
$85.24 - $94.15 $2,557 - $2,824
30 Added 0.64%
4,736 $432,000
Q1 2021

Aug 17, 2021

BUY
$83.5 - $98.47 $372,660 - $439,471
4,463 Added 1836.63%
4,706 $402,000
Q1 2021

May 12, 2021

BUY
$83.5 - $98.47 $20,290 - $23,928
243 New
243 $21,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.